- Open Access
Clinical indications and triaging for adult transthoracic echocardiography: a consensus statement by the British Society of Echocardiography in collaboration with British Heart Valve Society
Echo Research & Practice volume 9, Article number: 5 (2022)
Transthoracic echocardiography (TTE) is widely utilised within many aspects of clinical practice, as such the demand placed on echocardiography services is ever increasing. In an attempt to provide incremental value for patients and standardise patient care, the British Society of Echocardiography in collaboration with the British Heart Valve Society have devised updated guidance for the indications and triaging of adult TTE requests for TTE services to implement into clinical practice.
Transthoracic echocardiography (TTE) is widely accepted as the first choice non-invasive imaging modality for the assessment of cardiac structure and function. TTE is versatile, widely available and low-cost as such it forms a crucial part for a patient’s pathway throughout clinical practice including initial diagnosis, management and follow-up of many cardiac [1, 2] but also non-cardiac conditions.
The demand on TTE services continues to rise year upon year with data from National Health Service England indicating a ~ 3% increase in TTE activity for 2019 alone . This continued increase in activity will invariably result in delays to patients accessing TTE’s services. As such, the British Society of Echocardiography (BSE) in collaboration with the British Heart Valve Society (BHVS) have written an update to the previous ‘Clinical Indications for Echocardiography’  in an attempt to assist healthcare professionals in recognising when TTE is indicated and will provide incremental value to the management of a patient. This guide also provides guidance on the implementation of a standardised triaging system for TTE requests. It is thought that together this can achieve a more sustainable service for the benefit of our patients.
This guideline is based on evidence from relevant clinical studies and/or general agreement from clinical practice. It is intended to be used by all BSE members throughout the United Kingdom. It will be regularly reviewed (5 yearly) and updated in accordance with changes as directed by publications and/or changes in clinical practice as and when required. This guideline is not intended to include recommendations specifically relating to the practice of transoesophageal or stress echocardiography. Occasionally, attention may be drawn to circumstances where utilisation of an alternative cardiac imaging modality such as cardiac computed tomography (cCT) or cardiac magnetic resonance imaging (cMRI) may be preferable, this will be highlighted where appropriate.
It is important to recognise that although there is a need to expand and diversify TTE services, it remains imperative that a well performed TTE, undertaken by an appropriately trained healthcare professional, is essential to ensure a cost effective, high quality and sustainable TTE service . BSE do not support the implementation of level I or focussed TTE studies. Furthermore, BSE do not support the use of non-accredited healthcare professionals to facilitate the reduction in waiting lists. The BSE has published practical guidance on the minimum dataset recommended for a standard adult TTE  and these should be implemented in practice.
Incorporating clinical assessment by telephone into triage
For long-standing TTE referrals, individual services may wish to utilise appropriately trained clinical colleagues (Cardiology Consultant/Specialist Registrar, Cardiac Scientist or Specialist Cardiac Nurse) to re-contact patients to ascertain the clinical appropriateness and/or urgency of TTE request. The content of these discussions will be bespoke to each individual patient and should only be undertaken with sight of a patient’s medical records. This process may also be guided by locally available resources as outlined in Figs. 1 and 2. In light of these complex dependencies, triage using clinical assessment by telephone can be undertaken for follow-up requests if needed whilst acknowledging that it may be difficult to grade symptoms or undertake a clinical examination remotely. Furthermore, where follow-up periods of tests are lengthened, patients should be provided with the necessary information required to reconnect with the appropriate teams should there be a change in symptoms. It is vital that this is communicated sensitively to the patient explaining the rationale behind these decision. Any change in the patient’s clinical status should prompt a thorough reassessment.
Clinical indications and triage of echocardiography
Appropriateness criteria for TTE will be classified with respect to the sub-headings below.
Ward based and high dependency inpatients
Didactic timeframes for the delivery of echocardiography services are inherently difficult and this decision-making process will require careful balance with additional clinical pressures on staff. As a broad outline, if an appropriate outpatient TTE is received and is triaged as “indicated” this should be undertaken within a six week time frame. For TTE requests that are triaged as “urgent” this should be undertaken within a two week time frame (unless otherwise indicated in Table 1). The list provided is not exhaustive but is designed to provide a framework for departments to streamline service provision whilst giving clear guidance to referring healthcare professionals for when TTE is appropriate. It is advocated that sufficient time is devoted to accurate triage; national experience suggests that a clinical focus on triage is able to increase capacity for TTE delivery.
A complete and comprehensive overview of appropriate TTE indications can be seen in Table 1. Out-patient requests have been broadly divided into those most often referred for TTE. These include:
Suspected heart failure.
Hypertension and suspected left ventricular hypertrophy.
Suspected cardiac mass/possible cardiac cause of systemic-circulation embolism.
Pre-cardioversion in patients with atrial fibrillation.
Palpitations and pre-syncope/syncope.
Suspected pericardial disease.
Elective non-cardiac surgery.
These ‘most common’ referral indications have also undergone further sub-classification to determine appropriateness and urgency.
‘Not indicated’ TTE is unlikely to offer significant value to patient management and the request should therefore be declined.
‘Indicated’ TTE is appropriate and should be completed routinely.
‘Urgent’ TTE is appropriate and should be undertaken as a clinical priority.
It is acknowledged that patients with suspected heart failure may present with a variety of clinical signs and symptoms. Suspected heart failure referrals that are described as “urgent” are consistent with NICE guideline . Suspected heart failure referrals that are described as “indicated” are an attempt to include a broader range of clinical signs and symptoms where there is likely to be a high diagnostic yield for abnormality. Suspected heart failure referrals that are described as “not-indicated” are an attempt to reduce the rate of inappropriate referrals that are likely to yield a low level of abnormality whilst ensuring departments receive appropriate requests with pertinent details.
Ward based in-patient requests
The process for the handling of routine, urgent and emergency inpatient TTE referrals has been published previously . This comprises the following indications and should be subject to immediate triage.
Clinical suspicion of:
Circulatory failure due to hypovolaemia.
Acute decompensation in cardiac function.
Acute or severe valve pathology: critical aortic stenosis/regurgitation or mitral valve dysfunction.
Acute right heart impairment due to pulmonary embolus.
In addition to the above TTE guidance, the following indications and triage categories are specific to an inpatient setting (see Table 2). Where appropriate, inpatient TTE referrals are sub-classified with respect to urgency and subsequent change in clinical management of a given patient.
‘Not indicated’ TTE is unlikely to offer significant value to patient management and the request should be declined.
‘Indicated’ TTE is appropriate and should be completed as a non-urgent inpatient. Here, the timeframe is variable and will depend upon clinical need.
‘Urgent’ TTE is appropriate and should be undertaken within 24 h.
‘Emergency’ TTE is appropriate and should be undertaken within 60 min.
It is acknowledged that service design and capabilities will vary between centres and the above time frames are given as optimum targets.
For those patients requiring longer term TTE follow-up, effective triage of referrals is vitally important to ensure resources are allocated to those with the most appropriate clinical need. Local clinical pathways, staffing and specialist skill-sets will, in some part, dictate appropriateness and timing of follow-up in these patients. However, this guidance advocates triage of referrals by experienced Healthcare Professionals to ensure clinical needs are met and an effective service is delivered.
TTE follow-up has been sub-classified into native valve disease (see Tables 3, 4 and 5) and prosthetic valves, valve repair and aortic disease (see Table 6). Latest NICE guidance  advocates the use of BSE guidelines for the assessment of valve disease severity including aortic stenosis , tricuspid and pulmonary valve disease  and mitral valve disease . The included follow-up timeframes for native valve disease, valve replacement, valve repair and aortic diseases allow for standardisation of care and are in keeping with previously published literature [13,14,15,16]. The incorporation of “echo alerts” and “other alerts” are designed to highlight TTE features that should prompt urgent specialist review. There are no clinically significant differences between the recommendations herein and those published by the European Society of Cardiology  and the American College of Cardiology . Patients under the care of a valve clinic and who require “Cardiologist / urgent Cardiologist review” should be undertaken by a valve clinic Cardiologist with valve disease competencies and expertise as this promotes best practice .
It is also acknowledged that a considerable number of patients will have more complex disease (e.g., moderate to severe multi-valve disease or post-operative regurgitation with ventricular dysfunction). For these patients, an individualised approach is essential and discussion amongst the clinical team to advise on the surveillance scan period is recommended.
Cardio-oncology is a complex clinical field and established local pathways are encouraged. Discussion amongst key stakeholders is highly advised, and in certain situations it may be considered appropriate to extend out the interval between repeat TTE. However, where there is clinical deterioration with likely cardiac involvement, a shortened time interval between repeat TTE’s may be more appropriate. It is advocated that baseline left ventricular systolic function assessment prior to the use of potentially cardiotoxic chemotherapy agents is triaged and prioritised as an urgent request to prevent delays to the commencement of treatment. A joint BSE and British Cardio-Oncology Society guideline on the TTE assessment of adult cancer patients receiving anthracycline therapy has previously been published .
Implementation of new indications and triage guidelines into real world practice
To assess the impact of the new indications and triage guidelines on service provision, two clinical service audits were undertaken within an inpatient setting (Craigavon Area Hospital, Southern Health and Social Care Trust) and outpatient valve surveillance clinic setting (University Hospitals of North Midlands). Both clinical service audits were registered with the respective Trust's research and development departments.
Clinical service audit 1: Craigavon Area Hospital
Craigavon Area Hospital is a District General Hospital in Northern Ireland serving an estimated local population of 241,000. It is commissioned to perform over 10,000 TTE’s annually and has an inpatient bed capacity of 450. In an attempt to reduce inpatient TTE waiting times a service audit was undertaken in March 2021. Inpatient TTE referrals were collated over a two week period and reviewed against the BSE/BHVS indications as outlined in this document. Over this two week time frame 200 referrals were received and audited against the new BSE/NHSE guidance. The audit found that 95% of these referrals were undertaken within the recommended timeframes and 89% within 24 h. When inpatient TTE requests were vetted against the new BSE/NHSE guidance, 44.5% of requests were triaged as “not indicated” for an inpatient basis. This reduction in workload enabled the remaining appropriate inpatient TTE referrals to be completed in a more timely fashion. The audit findings were effectively used as an educational tool to improve the knowledge of appropriate inpatient TTE requests with clinical referring teams. It is hoped that this will translate to fewer inappropriate inpatient TTE’s being received in the future and enable patients with the greatest clinical need to have an inpatient TTE in a timely manner and allow for the freeing up of resources to be more effectively directed elsewhere.
Clinical service audit 2: University Hospital of North Midlands
The University Hospitals of North Midlands serves an estimated local population of 900,000. The centre has a Physiologist/Scientist led heart valve surveillance clinic which was established over 10 years ago. A clinical service audit was undertaken in November 2020 to better understand the patients’ demographics, valve aetiology/severity and follow-up requirements of the patient currently under its care. At the point of audit, the service incorporated the European Society of Cardiology guidelines for the management of valvular heart disease . The results showed there were 1504 patients within the service, mean age 69 years (range 20–99 years).
The most common native valve aetiology was aortic stenosis (30%) with mitral regurgitation and prosthetic valve replacements (aortic and mitral) accounting for 17% and 46% of patients respectively. This Physiologist/Scientist led service was shown to be safe with low between-appointment non-elective admission rates for patients with moderate/severe disease (5%) and a high proportion of patients referred for valvular intervention (80%) following referral back to medical follow-up when symptoms developed. The release of BSE/NHSE indications for valvular heart disease follow-up, as outlined in this document, prompted an additional audit to be undertaken to assess the impact of this on the follow-up duration of patients within the service.
All patients who attended the clinic in March 2021 were reviewed. A total of 88 patients were included (mean age 70 years, 62% male). Of these, 19.6% of patients’ no longer required routine follow-up due to either, mild aortic or mitral regurgitation with normal valvular structure and function or, mechanical valve replacements with no high risk features on baseline TTE. In 33.9% of patients, follow-up could be extended by an average of 41 months due to the presence of mild regurgitation or stenosis. This audit demonstrates that a portion of patients within heart valve surveillance clinics are potentially having follow-up at shorter time duration than is necessary. This may allow for follow-up frequency to be safely extended therefore increasing additional capacity within the service.
This updated guideline for TTE indications and triage has been produced to aid healthcare professions who refer patients for TTE ensuring that referrals are appropriate and timely. It also allows TTE services across the United Kingdom to standardise their triaging practice allowing limited resources to be directed to those patients in whom the results will most effectively guide diagnosis, management and/or future follow-up. The clinical audit findings presented demonstrate how these guidelines can be implemented into real world practice and have a positive impact on TTE services.
Availability of data and materials
British Society of Echocardiography
British Heart Valve Society
Cardiac computed tomography
Cardiac magnetic resonance
Computed tomography pulmonary artery
Left bundle branch block
Left ventricle/left ventricular
Left ventricular ejection fraction
Left ventricular hypertrophy
National Health Service England
National Institute of Health Care Excellence
- NT-pro BNP:
N-terminal pro-hormone brain natriuretic peptide
Patent foramen ovale
Right bundle branch block
Right ventricle/right ventricular
Transient ischemic attack
Rameh V, Kossaify A. Appropriate use criteria in echocardiography: an observational institutional study with the perspective of a quality improvement project. Clin Med Insights Cardiol. 2016. https://doi.org/10.4137/CMC.S36504.
Potter A, Pearce K, Hilmy N. The benefits of echocardiography in primary care. Br J Gen Pract. 2019;69(684):358–9. https://doi.org/10.3399/bjgp19X704513.
NHS England. NHS diagnostic waiting times and activity data. Leeds: NHS England and NHS improvement; 2019. https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2019/01/DWTA-Report-November-2018.pdf. Accessed 31st December 2020.
British Society of Echocardiography Clinical Indications for Echocardiography. https://bsecho.org/common/Uploaded%20files/Education/Protocols%20and%20guidelines/Indications%20for%20echocardiography.pdf. Accessed 3rd March 2021.
Robsinson S, Rana B, Oxborough D, Steeds R, Monaghan M, Stout M, Pearce K, Harkness A, Ring L, Paton M, Akhtar W, Bedair R, Bhattacharyya S, Collins K, Oxley C, Sandoval J, Schofiel R, Siva A, Parker K, Willis J, Augustine DX. A practical guideline for performing a comprehensive transthoracic echocardiogram in adults: the British Society of Echocardiography minimum dataset. Echo Res Pract. 2020;7(4):G59–93. https://doi.org/10.1530/ERP-20-0026.
NICE Guidance. Heart valve disease presenting in adults: Investigation and management [NG208]. https://www.nice.org.uk/guidance/ng208/chapter/Recommendations#referral-for-echocardiography-and-specialist-assessment. Accessed 23rd March 2022.
Mishra M, Chambers JB, Jackson G. Murmurs in pregnancy: an audit of echocardiography. BMJ. 1992;304:1413–4. https://doi.org/10.1136/bmj.304.6839.1413.
Northcote RJ, Knight PV, Ballantyne D. Systolic murmurs in pregnancy: value of echocardiographic assessment. Clin Cardiol. 1985;8:327–8. https://doi.org/10.1002/clc.4960080604.
NICE Guidance. Chronic heart failure in adults: diagnosis and management [NG106]. https://www.nice.org.uk/guidance/ng106/chapter/recommendations. Accessed 30th December 2020.
Hindocha R, Garry D, Ingram T, Colebourn C, Pearce K, Sharma V. A minimum dataset for a Level 1 echocardiogram: a guideline from the British Society of Echocardiography. Echo Res Pract. 2020;7(2):G51–8. https://doi.org/10.1530/ERP-19-0060.
Bergl PA, De Reguero U, Patel JJ. Things we do for no reason: routine echocardiography in hemodynamically stable patients with acute pulmonary embolism. J Hosp Med. 2019;14(4):242–5. https://doi.org/10.12788/jhm.3125.
Rhodes A, Evans LE, Alhazzani W, Levey MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annana D, Beale RJ, et al. Surviving sepsis campaign: international guidelines for the management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552. https://doi.org/10.1097/CCM.0000000000002255.
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Lung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, and the ESC Scientific Document Group. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. https://doi.org/10.1093/eurheartj/ehab395.
Chambers JB, Garbi M, Nieman K, Myerson S, Pierard LA, Habib G, Zamorano JL, Lancellotti P, Edvardse T, Delgado V, Cosyns B, Donal E, Dulgheru R, Galderisi M, Lombardi M, Muraru D, Kauffmann P, Cardim N, Haugaa K, Rosenhek R. Appropriateness criteria for the use of cardiovascular imaging in heart valve disease in adults: a European Association of Cardiovascular Imaging report of literature review and current practice. Eur Heart J Cardiovasc Imaging. 2017;18(5):489–98. https://doi.org/10.1093/ehjci/jew309.
Chambers JB, Garbi M, Briffa N, Sharma V, Steeds R. Indications for echocardiography of replacement heart valves: a joint statement from the British Heart Valve Society and British Society of Echocardiography. Echo Res Pract. 2019;6(1):G9–15. https://doi.org/10.1530/ERP-18-0079.
Borger MA, Fedak PWM, Stephens EH, Gleason TG, Girdauskas E, Ikonomidis JS, Khoynezhad A, Siu SC, Verma S, Hope MD, Cameron DE, Hammer DF, Coselli JS, Moon MR, Sundt TM, Barjer AJ, Markl M, Corte AD. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: executive summary. J Thorac Cardiovasc Surg. 2018;156(2):473–80. https://doi.org/10.1016/j.jtcvs.2018.02.115.
Ring L, Shah BN, Bhattacharyya S, Harkness A, Belham M, Oxborough D, Pearce K, Rana BS, Augustine DA, Robinson S, Tribouillo C. Echocardiography assessment of aortic stenosis: a practical guideline from the British Society of Echocardiography. Echo Res Pract. 2021;8(1):G19–59. https://doi.org/10.1530/ERP-20-0035.
Zaidi A, Knigh DS, Augustine DX, Harkness A, Oxborough D, Pearce K, Ring L, Robinson S, Stout M, Willis P, Sharma and the Education Committee of the British Society of Echocardiography. Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography. Echo Res Pract. 2020;7(1):G19–41. https://doi.org/10.1530/ERP-19-0051.
Robinson S, Ring L, Augustine DX, Rekhraj S, Oxborough D, Harkness A, Lancellotti P, Rana B. The assessment of mitral valve disease: a guideline from the British Society of Echocardiography. Echo Res Pract. 2021;8(1):G87–136. https://doi.org/10.1530/ERP-20-0034.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs K, Capodanno D, Conradi L, DeBonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppson A, Juni P, Peirard L, Prendergast BD, Sadaba JR, Tribouilloy C, Wojakowski W. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2021;42(7):561–632. https://doi.org/10.1093/eurheartj/ehab395.
Otto CM, Nishimurs RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundy TM, Thompson A, Toly C. 2020 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72–227. https://doi.org/10.1161/CIR.0000000000000923.
Lancellotti P, Rosenhek R, Pibarot P, Lung B, Ott CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Pierard L, Maurer G. ESC Working group on valvular heart disease position paper—heart valve clinics: organization, structure and experiences. Eur Heart J. 2013;34(21):1597–606. https://doi.org/10.1093/eurheartj/ehs443.
British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult patients receiving anthracyclines and/or trastuzumab. Echo Res Pract. 2021:8(1);G1-G18. https://doi.org/10.1530/ERP-21-0001.
This project arose through a round table workshop with the pan-London NHSE group looking at addressing the C-19 induced backlog of patients waiting for specialist tests including echocardiography. We wish to thank all individuals who have given their time and expertise involved in this process.
No funding was received for this guideline.
Ethics approval and consent to participate
Consent for publication
Both clinical audits were registered and approved by the centres research and audit departments. Not applicable to the remaining manuscript.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bennett, S., Stout, M., Ingram, T.E. et al. Clinical indications and triaging for adult transthoracic echocardiography: a consensus statement by the British Society of Echocardiography in collaboration with British Heart Valve Society. Echo Res Pract 9, 5 (2022). https://doi.org/10.1186/s44156-022-00003-8
- Transthoracic echocardiography